Response to tetanus anatoxin vaccination in elderly women: Prospective study during 42 months;Reponse a la vaccination par l'anatoxine tetanique chez la femme agee: Etude prospective sur 42 mois

Medecine et Maladies Infectieuses

Volumn 29, Issue 10, 1999, Pages 619-625

  Riazi, A ^a   Odelin, M F ^a   Lery, L ^b   Momplot, C ^a   Pozzetto, B ^c  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c HÔPITAL NORD   (France)

Author keywords

Antitetanic immunity; Elderly patient

Indexed keywords

TETANUS ANTIBODY; TETANUS TOXOID;

AGED; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HUMAN; HUMORAL IMMUNITY; HYPERSENSITIVITY REACTION; MAJOR CLINICAL STUDY; SEROCONVERSION; TETANUS PROPHYLAXIS;

EID: 0033213003     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(00)87137-1     Document Type: Article

References (16)

1. Public Health Laboratory Service Communicable Disease Surveillance Centre. Tetanus surveillance: England and Wales, 1981-3. Br Med J 1985 ; 290 : 696-7.
2. Ebisawa I, Homma R. Tetanus in Japan: Trends of mortality, case fatality and causes of death. Jpn J Exp Med 1986 ; 56 : 155-72.
3. Bardenheier B, Prevots DR, Khetsuriani N, Wharton M. Tetanus surveillance: United states, 1995-1997. Morb Mort Wkly Rep 1998 ; 47 : 1-13.
4. Stein BH. Vaccinating elderly people. Protecting from available diseases. Drugs Aging 1994 ; 5 : 242-53.
5. Réseau national de santé publique. Le tétanos en France en 1996. Bull Épidemiol Hebd 1998 ; n° spécial mars : 23-4.
6. Beytout D, Cailleba A, Dolci A, Nguyen TT, Mamouret A, Lauras H. Évaluation d'un test rapide de mesure de l'immunité antitétanique dans la pratique d'un service d'urgences. Presse Méd 1988 ; 17 : 2091.
7. Bistroni F, Marconi P, Perito S, Bastianini L, Antenucci R, PitzurraI M. Turkey red blood cell passive haemagglutination assay as guideline for specific prevention of tetanus in injured persons. Bull WHO 1985 ; 63 : 905-14.
8. Wellhoner HH. Immunology of tetanus: Basic and clinical aspects of tetanus. In: Veronesi R, éd. Tetanus. Important New Concepts. Amsterdam-Oxford-Princeton: Excepta Medica ; 1981. p. 40-108.
9. Penin F, Baustert C, Burdin JC, Cuny G. Enquête sur l'immunité antitétanique et résultat de la vaccination des sujets non protégés de plus de 60 ans vivant en hébergement médicalisé. Méd Hyg 1982 ; 40 : 1864-70.
10. Murphy SM, Hegarty DM, Feighery CS, Walsh JB, Williams Y, Coakley DP. Tetanus immunity in elderly people. Age Ageing 1995 ; 24 : 99-102.
11. Kishimoto S, Tomino S, Mitsuya H, Fujiwara H, Tsuda H. Age-related decline in the in vitro and in vivo synthesis of antitetanus toxoid antibody in humans. J Immunol 1980 ; 125 : 2347-52.
12. Yéni P, Carbon C, Trémolières F, Gibert C. Serum levels of antibody toxoid during tetanus and after specific immunization of patients with tetanus. J Infect Dis 1982 ; 142 : 278.
13. Takahashi M, Komiya T, Fukuda T, Nagaoka Y, Ishii R, Goshima F, et al. A comparison of young and aged populations for the diphtheria and tetanus antitoxin titers in Japan. Jpn J Med Sci Biol 1997 ; 50 : 87-95.
14. Burns EA, Lum LG, L'Hommedieu G, Goodwin JS. Specific humoral immunity in the elderly: In vivo and in vitro response to vaccination. J Gerontol 1993 ; 48 : 231-6.
15. Steger MM, Maczek C, Berger P, Grubeck-Loebenstein B. Die immunreaktion gegenüber tetanus im alter : Wie lange hält der impfschutz. Wien Klin Wochenschr 1997 ; 109 : 767-70.
16. Schatz D, Ellis T, Ottendorfer E, Jodoin E, Barrett D, Atkinson M. Aging and the immune response to tetanus toxoid: Diminushed frequency and level of cellular immune reactivity to antigenic stimulation. Clin Diagn Lab Immunol 1998 ; 5 : 894-6.